How Much Weight Per Week Can You Lose on Wegovy?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Patients starting semaglutide therapy often ask how quickly they'll see results on the scale. The short answer: weight loss typically becomes visible within the first 2 to 4 weeks, with most individuals losing between 1 and 2 pounds weekly during the initial dosing phase. However, the pace depends on your unique metabolic profile, adherence to healthy habits, and how your body responds to the medication.

Typical Weekly Weight Loss Rates on Semaglutide

Clinical trials with semaglutide document average weight reductions of 1 to 2 pounds per week during the first 12 weeks of treatment. This rate often accelerates when doses reach therapeutic levels, as appetite suppression becomes more pronounced and food intake naturally decreases. The STEP trials, which evaluated once-weekly semaglutide injections, showed cumulative weight loss of approximately 10% of body weight by week 16 in many participants.

Individual results vary significantly based on baseline metabolic factors, including insulin sensitivity, genetic predispositions, and how effectively your body's appetite-regulating pathways respond to GLP-1 agonists. Some patients experience rapid initial drops of 3 to 5 pounds in the first week due to fluid loss and reduced caloric intake, while others see steadier, more gradual decline over several weeks. The velocity of weight loss often plateaus after 12 to 16 weeks as your body adapts to the medication and caloric deficit.

Factors That Influence Your Personal Weight Loss Timeline

Your starting weight significantly shapes how quickly pounds drop—individuals with higher baseline body mass index often experience more rapid initial weight loss compared to those with lower starting weights. Genetic variations in appetite-regulating peptide pathways, such as GLP1R and GIPR gene variants, influence how strongly your body responds to semaglutide's signaling effects. PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and identifies your unique peptide-response profile, helping predict personalized outcomes before starting treatment.

Dosing progression also affects the timeline—your dose may need to go up over weeks or months to reach the level that produces maximum appetite suppression for your body. Diet quality, physical activity level, sleep patterns, and stress management all interact with medication effects to determine actual weight loss velocity. Patients who combine semaglutide with consistent calorie awareness and moderate exercise typically see faster, more sustainable results than those relying on medication alone.

What Happens After the First Month of Semaglutide Treatment

By the end of month one, many patients have lost 3 to 8 pounds, though this wide range reflects the diversity of individual responses. The medication's full appetite-suppressing effect requires dose titration—starting doses are low to minimize nausea and other side effects, then gradually increased every 4 weeks until reaching the maintenance dose your body tolerates and responds to optimally. This gradual escalation means weight loss accelerates as doses increase, rather than remaining constant week to week.

Months 2 through 6 typically show continued steady weight loss of 1 to 3 pounds per week as your therapeutic dose stabilizes and your body adapts to reduced food intake. Beyond 6 months, weight loss velocity often slows as you approach a new equilibrium weight—this is expected and normal, not a sign that the medication has stopped working. Long-term semaglutide therapy helps maintain the weight you've lost rather than continuing unlimited downward progression.

Making the Most of Your Semaglutide Treatment for Sustainable Results

Maximizing weight loss on semaglutide involves addressing both medication response and lifestyle factors simultaneously. PlexusDx Semaglutide Injection starts at $149 per month, providing access to compounded semaglutide from licensed 503A pharmacies—no insurance required, no membership fees, and HSA/FSA eligible. The flat monthly pricing means your dose may increase as your treatment progresses, but your price remains the same, removing cost-related barriers to reaching your optimal therapeutic dose.

Beyond medication, focus on protein intake at each meal to preserve muscle mass during weight loss, stay consistently hydrated, and engage in regular movement that you enjoy—these habits amplify semaglutide's effects and support long-term weight maintenance. Regular monitoring of your progress and adjusting your approach based on what you observe helps identify whether you're responding optimally or whether personalized adjustments may benefit you. Discussing your specific results and timeline with your PlexusDx provider ensures you're on track for your individual health goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose 5 pounds per week on semaglutide?

While some patients experience rapid initial drops of 3 to 5 pounds in week one (mostly fluid and reduced food volume), sustaining a 5-pound weekly loss long-term is uncommon and not typical in clinical trials. Average sustainable weight loss is 1 to 2 pounds per week during active dose escalation, with individual variation based on metabolic factors and adherence to calorie awareness.

How long until I notice weight loss starting on semaglutide?

Most patients observe measurable weight loss within 2 to 4 weeks of starting semaglutide therapy, though initial appetite suppression often appears within the first week. The visible scale changes typically accelerate once your dose reaches therapeutic levels and your body's appetite-regulating pathways fully engage with the medication.

Is PlexusDx semaglutide the same as brand-name Wegovy?

PlexusDx Semaglutide Injection is a compounded version manufactured by licensed 503A pharmacies, containing the same active ingredient as brand-name Wegovy but at a significantly lower cost—starting at $149 per month compared to brand prices exceeding $900. Both work through identical GLP-1 agonist mechanisms, though compounded versions may have slightly different fillers and preservatives.

What if my weight loss slows down after a few months?

Plateaus are a normal part of weight loss physiology and don't mean the medication has stopped working. Adjusting your dose, refining your diet approach, increasing physical activity, or investigating sleep and stress factors can help restart progress. PlexusDx providers can review your response and recommend personalized adjustments to support continued results.

Can the Precision Peptide Genetic Test predict how fast I'll lose weight?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, helping predict how strongly your body's appetite regulation will respond to semaglutide. This insight allows your provider to optimize your starting dose and escalation plan for faster, more predictable results based on your unique metabolic blueprint.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.